Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ITR Laboratories is a non-clinical contract research organization (CRO) based in Montreal, Canada, primarily serving pharmaceutical and biotechnology companies. Its website positions the company as a “global partner in drug development.” Rather than being a traditional SaaS product, its core offering is professional laboratory services focused on drug safety assessment, toxicology studies, and GLP-compliant data delivery, while also incorporating an AI-driven In Silico toxicity prediction platform.
Based on the information disclosed, ITR covers three categories of toxicology services: In Silico, In vitro, and In vivo. Its computational toxicology services emphasize AI/machine-learning-based toxicity prediction for early decision-making and project financing support. Its in vitro platform highlights humanized models, high-throughput screening, and targeted toxicity assessment. Its in vivo studies cover multiple administration routes, various study durations, species, safety pharmacology, biologics, and small molecules. Its pathology team also provides clinical pathology, necropsy, histopathology, IHC, biomarker analysis, and method development and validation. Supporting capabilities include pharmacy services, PK/TK non-compartmental analysis, independent QA, on-site and off-site electronic archiving, Provantis data capture, electronic reporting, and SEND-ready outputs.
The website does not provide standard packages, subscription pricing, or a free trial. It only offers a “Request a Proposal” option, indicating that its business model is more project-based with customized quotations. For teams that need a clear budget, the scope, timeline, and cost will need to be determined through upfront proposal discussions.
Its strengths lie in its qualifications and experience: the website states that the company was founded in 1989, has more than 35 years of experience, has completed nearly 6,000 studies, and has passed FDA and EMA inspections, with AAALAC and CCAC accreditation as well as a GLP system. In terms of facilities, it discloses 185,000 square feet of space, animal rooms, inhalation toxicology exposure rooms, environmental monitoring, and backup for critical systems. The downside is that it is not a self-service SaaS product: it does not disclose APIs, permission systems, cloud deployment, developer support, or an online purchasing process.
It is better suited for pharmaceutical companies, biotechnology firms, and early-stage R&D teams that need IND-enabling studies, GLP toxicology, safety pharmacology, pathology, and regulatory submission data. The website does not provide information about access from China, so this remains unknown. For cross-border projects, teams should additionally confirm communication time zones, sample/data transfer processes, compliance requirements, and quotation details.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on itrlab.com official site.
itrlab.com is an Canada Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach itrlab.com directly.